Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
|
|
ALEXION PHARMACEUTICALS, INC. (ALXN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2018 |
BW
| Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study |
| 04/12/2018 |
BW
| Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018 |
| 02/08/2018 |
BW
| Alexion Reports Fourth Quarter and Full Year 2017 Results and Provides Financial Guidance for 2018 |
| 01/31/2018 |
BW
| Alexion to Present at the Leerink Partners 7th Annual Global Healthcare Conference |
| 01/18/2018 |
BW
| Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018 |
| 01/02/2018 |
BW
| Alexion to Present at the 36th Annual J.P. Morgan Healthcare Conference |
| 12/20/2017 |
BW
| Alexion to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference |
| 11/27/2017 |
BW
| Alexion to Present at the Citi 2017 Global Healthcare Conference |
| 10/26/2017 |
BW
| Alexion Reports Third Quarter 2017 Results |
| 10/10/2017 |
BW
| Alexion to Report Third Quarter 2017 Results on Thursday, October 26, 2017 |
| 09/12/2017 |
BW
| Alexion Announces Restructuring to Advance Corporate Strategy |
| 09/05/2017 |
BW
| Alexion to Present at Upcoming Investor Conferences |
| 07/27/2017 |
BW
| Alexion Reports Second Quarter 2017 Results |
| 07/11/2017 |
BW
| Alexion to Report Second Quarter 2017 Results and Strategic Update on Thursday, July 27, 2017 |
| 05/30/2017 |
BW
| Alexion to Present at Upcoming Investor Conferences |
| 05/09/2017 |
BW
| Alexion to Present at the Bank of America Merrill Lynch 2017 Health Care Conference |
| 04/27/2017 |
BW
| Alexion Reports First Quarter 2017 Results |
| 04/06/2017 |
BW
| Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017 |
| 02/16/2017 |
BW
| Alexion Reports Fourth Quarter and Full Year 2016 Results and Provides Financial Guidance for 2017 |
| 07/21/2011 |
BW
| Alexion Reports Second Quarter 2011 Results |
| 06/20/2011 |
BW
| Alexion Initiates Clinical Trial of Eculizumab as a Potential Treatment for Patients with STEC-HUS in Expanded Response to EHEC Crisis in Germany |
| 06/07/2011 |
BW
| Alexion to Present at the 31st Annual William Blair & Company Growth Stock Conference |
| 05/31/2011 |
BW
| Alexion to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference |
| 05/23/2011 |
BW
| Researchers to Present Nine Studies on Soliris® (eculizumab) in Patients with PNH and aHUS at EHA Congress |
| 04/26/2011 |
BW
| Alexion to Present at Deutsche Bank Securities 36th Annual Health Care Conference |
| 04/21/2011 |
BW
| Alexion Reports First Quarter 2011 Results |
| 04/08/2011 |
BW
| Alexion Pharmaceuticals to Report First Quarter 2011 Results on Thursday, April 21, 2011 |
| 04/07/2011 |
BW
| Alexion Submits Applications for Soliris® (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union |
| 03/30/2011 |
BW
| Alexion Announces Two-For-One Stock Split |
| 03/29/2011 |
BW
| Alexion to Present at the 10th Annual Needham Healthcare Conference |
| 03/01/2011 |
BW
| Alexion to Present at the Cowen and Company 31st Annual Health Care Conference |
| 02/28/2011 |
BW
| Alexion Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2011 |
| 02/22/2011 |
BW
| Alexion to Present at the Citi 2011 Global Health Care Conference |
| 02/10/2011 |
BW
| Alexion Reports Fourth Quarter and Full Year 2010 Results |
|
|
|